Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2

• Main Authors: Lu Chen (Author), Le Chen (Author), Zhiyuan Qin (Author), Jinxiu Lei (Author), Sheng Ye (Author), Kui Zeng (Author), Hua Wang (Author), Meidan Ying (Author), Jianqing Gao (Author), Su Zeng (Author), Lushan Yu (Author)
• Format: Book
• Published: Elsevier, 2019-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Renal cell carcinoma (RCC) is one of the most common malignant tumors affecting the urogenital system, accounting for 90% of renal malignancies. Traditional chemotherapy options are often the front-line choice of regimen in the treatment of patients with RCC, but responses may be modest or limited d...